MED-EL, which is headquartered in Innsbruck, is a leading provider of hearing implant systems. The family-owned business, which was founded by Dr. Ingeborg and Prof. Dr. Erwin Hochmair, is one of the pioneers of the industry, and the inventor of the Cochlear Implant in the form in which it is known today.
MED-EL established its presence in the Middle East and North Africa market in the early 1990's. Since then it has become the largest supplier of hearing implants in the region, and has a growing network of exclusive and trusted partnerships with the region's leading hospitals and doctors.
Today, MED-EL offers the widest range of implantable solutions to treat the various types and degrees of hearing loss. And, continues to invest in research, design and development to achieve its adamant missionof assisting patients in overcoming hearing loss as a barrier to communication.
Research activity at MED-EL is driven by the development of new hearing implant technologies and the constant improvements made in cooperation with medical scientists.
New standards, innovations, and industry "firsts" demonstrate the consistent commitment of the company. Some of the most exciting innovations include EAS technology (Electric Acoustic Stimulation), which can significantly improve the quality of life for people with partial deafness. MED-EL was also the proud innovator of the first active bone conduction implant - BONEBRIDGE.
Most recently, MED-EL introduced the SYNCHRONY Cochlear Implant system; it is the only cochlear implant that is designed for high-resolution 3.0 Tesla MRI scans with the implant magnet in place.
With the SYNCHRONY implant, patients have the peace of mind knowing they have chosen the only implant that delivers exceptional hearing performance, outstanding reliability, and unmatched MRI safety. Additionally, the SYNCHRONY Implant system is the smallest and lightest titanium implant available, offering proven stability and flexible atraumatic electrodes ensuring an optimal solution to all candidates, especially for small children.
As the global leader in implantable hearing solutions, CochlearTM is dedicated to bringing the gift of sound to people with moderate to profound hearing loss. We have helped over 450,000 people of all ages live full and active lives by reconnecting them with family, friends and community.
We aim to give our recipients the best lifelong hearing experience and access to innovative future technologies. For our professional partners, we offer the industry's largest clinical, research and support networks. That's why more people choose Cochlear that any other hearing implant company.
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges - such as rising costs, aging populations and the burden of chronic disease - faced by families and healthcare systems today. But no one can do it alone. That's why we're committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes.
Founded in 1949 as a medical repair company, we're now among the world's largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 155 countries. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.
In 1945, Dr. Karl Storz created instruments for the ENT specialist marking the beginning of an era of innovation. KARL STORZ offers a complete package, from rigid to flexible endoscopes and around 6,000 different instruments for diagnostic & surgical solutions. The range of products covers Sinus, Ear, Laryngeal , Skull Base, as well as Head & Neck surgeries in addition to OTO-Neurosurgery. The innovation extends to new techniques like Endoscopic Ear & Laryngeal surgery.
As technology evolved further and following our vision to further support adoption of Minimally Invasive Surgery in close collaboration with physicians and experts in the field of Oto-Rhino-Laryngology, ongoing development paved the way for the release of new innovative products. Additional innovative tools included the KARL STORZ NAV1 Navigation System, UNIDRIVE SIII Motor System, TIPCAM1 S 3D 4mm telescope, VITOM® 3D, EndoCAMeleon and the IMAGE1 S Full HD Imaging Systems.
Abbott has a rich heritage and history that goes back more than 125 years, when our company was founded by Chicago physician Wallace C. Abbott. Now, Abbott has become one of leading broad based global health care company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Our comprehensive line of products encircles life itself -addressing important health needs from infancy to the golden years.
Abbott appoints nearly 70,000 employees and have a presence in more than 130 countries. We are here for the people we serve in their pursuit of healthy lives. This has been the way of Abbott for more than a century - passionately and thoughtfully translating science into lasting contributions to health.
Abbott was also named top dealmaker for four consecutive years due to the big number of transformations such as acquisitions and mergers, with the most recent, acquisition of ex-Solvay and split of AbbVie (one of Abbott major division) into a separate entity.
Values are the foundation for building a meaningful corporate identity. While Abbott is a company rooted in values, not all values can shape a company's identity in a meaningful and differentiating way. For instance, Abbott's core values of honesty, integrity and fairness describe a standard of behavior expected of every Abbott employee.
Vienna Trading Establishment is part of the Al Batha Group of companies (Owned by His Highness Sh. Sultan Bin Mohammad Sultan Al Qasimi). The Al Batha group is one of the largest private business groups in the UAE. The group consists of around 25 autonomous companies in the diversified sectors of Medical/Pharmaceutical, Automobiles, Contracting, Manufacturing, Electronics, FMCG, Real Estate, and Education etc. and has over 4500 employees.
With the collaboration with Nucleus Cochlear Implant & Phonak companies we aim to play a major role in providing hearing solutions for the population of United Arab Emirates - Nucleus Cochlear Implant System for electrical stimulation & Phonak for acoustic stimulation where, Phonak is a part of Sonova Group. Both Phonak & Nucleus are market leaders in innovation & delivering performance. We are pleased to inform that with these two companies we are collaborating very closely and in the near future we will see new products on the market which bring together their technologies for the benefit of our patients with hearing disability.
Think globally act locally is a precise definition of our corporate culture. Amico is a leader and pioneer in number of medical fields. The company markets and services broad line of surgical and diagnostic equipment and devices used in ophthalmology, Dermatology, Neurosurgery, Orthopedics, Plastic surgery, ENT, OR solution, Hospital Supply and optical. All of our divisions Successfully engage in Marketing, servicing and customer support. At Amico we have intimate knowledge of the Local market, emerging Local trend, economic changes and cultural differences throughout the GCC, levant countries, Iraq, North Africa , Iran and Pakistan.
Gulf Medical Projects Company, is a well-established company and professionally managed public limited holding company since 1979. Dr. Sheikh Faisal Bin Khalid Al Qassimi is the Chairman of its Board of Directors. Mr. Salem Abdulla Salem is the Vice Chairman and Sheikh Majid Bin Faisal Al Qassimi is our Managing Director.
The aims and objectives of our company are to build and manage our own hospitals, to equip and service Government and private hospitals,
All the commercial activities are managed by GULF MEDICAL COMMERCIAL AGENCIES the trading division in G.M.P.C. which is fully owned by G.M.P.C.'s directors and managed by Dr. Rasoul Mousannef as General Manager.
We represent the following reputed manufactures in U.A.E.
- Otopront®, Germany - Otolaryngology units & ENT Clinics Equipments.
- ARRI Medical®, Germany - Pioneers in Digital 3D ENT Surgical Microscopes.
- ERBE®, Germany - Electrosurgical Machines & Cryo Surgery Machines
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Olympus is one of the world's leading manufacturers of innovative optical and digital equipment such as endoscopes and microscopes for medical, scientific and industrial use as well as cameras and voice recorders. Founded in Japan in 1919, Olympus has stood for pioneering spirit and innovation for more than 90 years.
Olympus is focused on providing advanced solutions to meet our customers' clinical ENT needs. Our innovative technologies deliver superior endoscopic imaging and video, powered instrumentation, hand instruments, implantable devices, and surgical supplies.